Loading...
Clinicians caring for women with epilepsy (WWE) during pregnancy must carefully balance risks from inadequate seizure control against risks for adverse outcomes associated with exposure to antiseizure medications (ASMs). Limited data suggest higher maternal morbidity in WWE. To better understand the associations between epilepsy, ASM exposure, and maternal and perinatal outcomes, researchers conducted a prospective, Nordic population–based cohort study between 1996 and 2017. They linked maternal diagnosis of epilepsy and ASM prescriptions filled during pregnancy with selected adverse outcomes between 22 weeks' gestation and 42 days' postpartum. The primary outcomes were a composite of severe maternal morbidity and mortality (e.g., death, or…